11:09 AM EST, 02/20/2025 (MT Newswires) -- Ginkgo Bioworks ( DNA ) said Thursday it is collaborating with the European Health and Digital Executive Agency, or HaDEA, as the contracting authority under a joint tender of up to 24 million euros ($25.1 million).

The project aims to develop a solution to enable hospitals to achieve fast turnaround diagnostics for respiratory viruses. The program will be executed in multiple phases, including clinical trials in EU hospitals before regulatory approval, the company said.

Ginkgo said that under the award, the company and its consortium partners are eligible to receive up to 24 million euros over the next four years.

The funding is made available via the EU4Health program, which aligns with the key priorities of the Health Emergency Preparedness and Response Authority (HERA) of the European Commission, the company said.

Ginkgo shares were falling past 6% in recent trading.

Price: 11.90, Change: -0.79, Percent Change: -6.19